Cost-effectiveness of a 24-month fixed duration of venetoclax in combination with rituximab in relapse/refractory chronic lymphocytic leukaemia Meeting Abstract


Authors: Coll Bastus, N.; Bennison, C.; Durno, N.; Sail, K.; Alexiou, D.; Mato, A.; Eyre, T. A.; Follows, G.
Abstract Title: Cost-effectiveness of a 24-month fixed duration of venetoclax in combination with rituximab in relapse/refractory chronic lymphocytic leukaemia
Meeting Title: 60th Annual Scientific Meeting of the British Society for Haematology (BSH)
Journal Title: British Journal of Haematology
Volume: 189
Issue: Suppl. 1
Meeting Dates: 2020 Apr 27-29
Meeting Location: Birmingham, UK
ISSN: 0007-1048
Publisher: John Wiley & Sons  
Date Published: 2020-04-01
Start Page: 106
End Page: 107
Language: English
ACCESSION: WOS:000528597400143
PROVIDER: wos
PUBMED: 32337705
DOI: 10.1111/bjh.16638
Notes: Meeting cancelled due to COVID-19 pandemic -- Meeting Abstract: BSH2020-PO-095 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Anthony R Mato
    235 Mato